KCB Group PLC (NASE:KCB)
47.30
-0.10 (-0.21%)
At close: Aug 1, 2025
Intra-Cellular Therapies Market Cap
KCB Group has a market cap or net worth of 152.00 billion as of August 1, 2025. Its market cap has increased by 36.51% in one year.
Market Cap
152.00B
Enterprise Value
n/a
Revenue
176.34B
Ranking
n/a
PE Ratio
2.53
Stock Price
$47.30
Market Cap Chart
Since December 20, 2004, KCB Group's market cap has increased from 12.97B to 152.00B, an increase of 1,072.33%. That is a compound annual growth rate of 12.67%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 152.00B | 13.70% |
Dec 31, 2024 | 133.68B | 89.95% |
Dec 29, 2023 | 70.37B | -42.52% |
Dec 30, 2022 | 122.43B | -16.17% |
Dec 31, 2021 | 146.05B | 19.29% |
Dec 31, 2020 | 122.43B | -26.05% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Safaricom | 1,115.82B |
Equity Group Holdings | 189.63B |
East African Breweries | 176.20B |
Standard Chartered Bank Kenya | 117.23B |
NCBA Group | 108.32B |
Absa Bank Kenya | 105.91B |
The Co-operative Bank of Kenya | 99.74B |
Stanbic Holdings | 69.97B |